BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34988055)

  • 41. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
    Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
    Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determinants of health-related quality of life among homeless individuals during the COVID-19 pandemic.
    van Rüth V; König HH; Bertram F; Schmiedel P; Ondruschka B; Püschel K; Heinrich F; Hajek A
    Public Health; 2021 May; 194():60-66. PubMed ID: 33865148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predicting Patient-Level 3-Level Version of EQ-5D Index Scores From a Large International Database Using Machine Learning and Regression Methods.
    Zrubka Z; Csabai I; Hermann Z; Golicki D; Prevolnik-Rupel V; Ogorevc M; Gulácsi L; Péntek M
    Value Health; 2022 Sep; 25(9):1590-1601. PubMed ID: 35300933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Health-Related Quality of Life of People with Self-Reported Hypertension: A National Cross-Sectional Survey in China.
    Yao Q; Liu C; Zhang Y; Xu L
    Int J Environ Res Public Health; 2019 May; 16(10):. PubMed ID: 31100800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing outcomes for cost-utility analysis in mental health interventions: mapping mental health specific outcome measure GHQ-12 onto EQ-5D-3L.
    Lindkvist M; Feldman I
    Health Qual Life Outcomes; 2016 Sep; 14(1):134. PubMed ID: 27644119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Swedish experience-based value sets for EQ-5D health states.
    Burström K; Sun S; Gerdtham UG; Henriksson M; Johannesson M; Levin LÅ; Zethraeus N
    Qual Life Res; 2014 Mar; 23(2):431-42. PubMed ID: 23975375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of individual and social time trade-off values for health states in the general population.
    Burström K; Johannesson M; Diderichsen F
    Health Policy; 2006 May; 76(3):359-70. PubMed ID: 16214258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparing and transforming PROMIS utility values to the EQ-5D.
    Hartman JD; Craig BM
    Qual Life Res; 2018 Mar; 27(3):725-733. PubMed ID: 29264776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Media Influence on Anxiety, Health Utility, and Health Beliefs Early in the SARS-CoV-2 Pandemic-a Survey Study.
    Greenhawt M; Kimball S; DunnGalvin A; Abrams EM; Shaker MS; Mosnaim G; Comberiati P; Nekliudov NA; Blyuss O; Teufel M; Munblit D
    J Gen Intern Med; 2021 May; 36(5):1327-1337. PubMed ID: 33629267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. General population normative data for the EQ-5D-3L in the five largest European economies.
    Janssen MF; Pickard AS; Shaw JW
    Eur J Health Econ; 2021 Dec; 22(9):1467-1475. PubMed ID: 34117986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In search of a 'pan-European value set'; application for EQ-5D-3L.
    Sajjad A; Versteegh MM; Santi I; Busschbach J; Simon J; Roijen LH
    BMC Med Res Methodol; 2023 Jan; 23(1):13. PubMed ID: 36635625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the HUI3 and the EQ-5D-3L in a nursing home setting.
    Lung T; Howard K; Etherton-Beer C; Sim M; Lewin G; Arendts G
    PLoS One; 2017; 12(2):e0172796. PubMed ID: 28234983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
    Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
    Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EQ-5D-5L Slovenian population norms.
    Prevolnik Rupel V; Ogorevc M
    Health Qual Life Outcomes; 2020 Oct; 18(1):333. PubMed ID: 33028345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Variations in Patients' Overall Assessment of Their Health Across and Within Disease Groups Using the EQ-5D Questionnaire: Protocol for a Longitudinal Study in the Swedish National Quality Registers.
    Teni FS; Rolfson O; Devlin N; Parkin D; Nauclér E; Burström K;
    JMIR Res Protoc; 2021 Aug; 10(8):e27669. PubMed ID: 34448726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validity of EQ-5D-5L in stroke.
    Golicki D; Niewada M; Buczek J; Karlińska A; Kobayashi A; Janssen MF; Pickard AS
    Qual Life Res; 2015 Apr; 24(4):845-50. PubMed ID: 25347978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
    Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
    Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessing the external validity of algorithms to estimate EQ-5D-3L from the WOMAC.
    Kiadaliri AA; Englund M
    Health Qual Life Outcomes; 2016 Oct; 14(1):141. PubMed ID: 27716347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adapting the EQ-5D-3L for adults with mild to moderate learning disabilities.
    O'Dwyer JL; Bryant LD; Hulme C; Kind P; Meads DM
    Health Qual Life Outcomes; 2024 Apr; 22(1):37. PubMed ID: 38685039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.